in hospitalized 2019-nCoV patients (ChiCTR2000029308) are currently in progess.
Table 3 Antiviral agents for community-acquired respiratory viral infections (RVIs) and relevance to critically ill patients
Mechanism of action Target Virus Resistance Formulation Applicability to critically ill patients
Amantadi